Minocycline (multiple brands), a broad-spectrum antibiotic frequently used to treat acne, may be a useful adjunct to improve global functioning and quality of life in people with major depressive disorder (MDD), new research shows. "This study provides preliminary evidence of the. Can minocycline, a tetracycline antibiotic which has inflammatory and immunomodulating properties be used as an adjunct in depression?. The purpose of this study is to evaluate minocycline as a potential treatment for bipolar depression when added to a mood-stabilizing medication. Minocycline is .
Minocycline is a broad-spectrum tetracycline antibiotic, and has a broader spectrum than the . A double-blind, placebo-controlled study of minocycline for depression in , adds to the growing body of literature addressing whether. Recently depression is conceptualized as an immune-inflammatory and nitro- oxidative stress related disorder. Minocycline is a tetracycline. Minocycline has a large antidepressant effect and good tolerability Efficacy and tolerability of minocycline for depression: a systematic review.
Researchers at Deakin University took a biological approach to treating major depression by adding a daily dose of minocycline - a. Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial. This leaflet answers some common questions about MINOMYCIN. It does not contain all the available information. It does not take the place of talking to your. Aspirin and minocycline may be efficacious adjunctive treatments for bipolar depression. Given their potential import, additional studies to.